Alpine Global Management’s G1 Therapeutics, Inc. Common Stock GTHX Stock Holding History

Alpine Global Management’s Portfolio GTHX Stock Details GTHX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-46,728	Closed	-$107K	–	512
2024 Q2	$107K	Buy	+46,728	New	+$178K	0.02%	403
2023 Q1	–	Sell	-24,085	Closed	-$131K	–	462
2022 Q4	$131K	Buy	+24,085	New	+$202K	0.04%	121
2020 Q1	–	Sell	-15,760	Closed	-$417K	–	467
2019 Q4	$417K	Buy	+15,760	New	+$369K	0.09%	188

Alpine Global Management's GTHX Position: Q3 2024 in Review

Alpine Global Management sold out of G1 Therapeutics, Inc. Common Stock (GTHX) in Q3 2024, closing a stake of 46,728 shares — an estimated $107K sold.

Alpine Global Management first reported a position in GTHX in Q4 2019 and held it in 3 quarters. The position peaked at $417K in Q4 2019. 0 funds tracked by Wall St. Rank hold GTHX as of Q3 2024.

Alpine Global Management reported no remaining G1 Therapeutics, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
Alpine Global Management sold 46,728 G1 Therapeutics, Inc. Common Stock shares in Q3 2024, an estimated $107K.
Alpine Global Management first reported a position in G1 Therapeutics, Inc. Common Stock in Q4 2019 and held it in 3 quarters.
Alpine Global Management's G1 Therapeutics, Inc. Common Stock position peaked at $417K in Q4 2019.
0 funds tracked by Wall St. Rank held G1 Therapeutics, Inc. Common Stock as of Q3 2024.

Based on Alpine Global Management's 13F filing for Q3 2024, filed 14 Nov 2024.